Blog

Science Group (LSE:SAG) has issued a trading update for the nine months to 30 September 2025, reporting record Adjusted Operating Profit despite challenging macroeconomic conditions. A substantial pre-tax gain from a strategic investment in the first half of the year further boosted its strong cash position.

Recovery in the R&D services segment — particularly within the Medical sector — continues to drive growth, keeping the company on course to meet or exceed its full-year performance expectations. Science Group also remains committed to returning capital to shareholders through regular dividends and share buy-back programs.

The company’s robust financial performance, underpinned by healthy revenue and profit growth and solid cash generation, supports an attractive valuation that may signal potential upside for investors. However, technical indicators point to short-term bearish momentum, suggesting some near-term caution.

About Science Group

Science Group is an international professional services and systems company delivering innovation through the integration of science, technology, and engineering. Known for its strong R&D expertise, especially in the Medical sector, the company also pursues strategic investments and prioritizes shareholder returns as a core element of its business strategy.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Strategic Minerals (LSE:SML) has reported outstanding drilling results from its Redmoor project in Cornwall, confirming the presence of multiple zones of high-grade tungsten mineralization. The findings strengthen Redmoor’s position as one of the world’s highest-grade undeveloped tungsten deposits and highlight its growing strategic value amid rising global tungsten prices.

The company also indicated that the drilling data points to additional mineralized zones, which will be incorporated into an upcoming mineral resource estimate update. This could further enhance the project’s economic potential and Strategic Minerals’ market positioning.

While the company’s financial outlook shows signs of solid recovery and an attractive valuation profile, technical indicators hint at possible short-term weakness. Elevated historical volatility also remains a factor for investors to consider.

About Strategic Minerals

Strategic Minerals plc is an international exploration and production company focused on developing mineral resources. Its flagship asset is the Redmoor tungsten-tin-copper project in Cornwall, UK — a high-grade deposit with significant strategic importance in the global critical minerals market.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Oxford Instruments (LSE:OXIG) has reported a mixed first-half performance for 2025. While its Imaging and Analysis division was impacted by tariffs and a challenging economic backdrop, the Advanced Technologies segment delivered solid growth, buoyed by strong demand in the compound semiconductor market.

Despite a dip in overall revenue, the company anticipates a stronger second half, supported by cost-saving programs and targeted strategic initiatives. Management expects full-year results to remain stable on an organic constant currency basis, reinforcing confidence in its operational resilience.

Oxford Instruments continues to display strong financial fundamentals and positive technical indicators. However, valuation concerns persist, as its elevated P/E ratio suggests the stock may be priced at a premium. The company’s robust revenue base and healthy balance sheet remain key strengths.

About Oxford Instruments

Oxford Instruments is a global leader in advanced scientific technologies, serving academic and commercial clients in materials analysis, semiconductors, and healthcare & life sciences. Established in 1959 and listed on the London Stock Exchange, the company is committed to driving innovation that supports a greener, healthier, and more productive world.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Avacta Group PLC (LSE:AVCT) has announced that it will present new data on its first dual-payload peptide drug conjugate (PDC) at an upcoming international conference. This innovative therapy enables the targeted and controlled delivery of two cancer-fighting drugs from a single molecule, a major advancement that could enhance treatment outcomes and help overcome resistance in tumors.

While the company’s financial performance remains a challenge, with negative earnings weighing on its valuation, strong technical indicators offer some positive signals. Recent strategic developments discussed in the earnings call reflect progress in the company’s oncology pipeline despite ongoing fiscal headwinds.

About Avacta Group

Avacta is a clinical-stage life sciences company developing an advanced drug delivery technology known as the pre|CISION® platform. This approach allows existing oncology drugs to be re-engineered as peptide drug conjugate payloads, concentrating their therapeutic effect in tumors while minimizing toxicity and side effects for patients.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Mosman Oil and Gas Limited (LSE:MSMN) has revealed an internal estimate of 1,072 MMcf of prospective helium resources at its Coyote Wash Project in Colorado. The project is located in a region with a proven track record of helium production, and the estimate draws on data from surrounding wells combined with reprocessed seismic analysis.

The company plans to work with Sproule ERCE to conduct an independent assessment and certification of the resource. A positive evaluation could substantially strengthen Mosman’s helium portfolio and advance its broader U.S. growth strategy in this sector.

Despite this promising development, Mosman continues to face financial pressures, including weak profitability and challenging valuation metrics. While technical indicators hint at moderate momentum and the company benefits from a solid equity base and a strategic shift toward helium, ongoing cash flow constraints remain a key obstacle.

About Mosman Oil and Gas

Mosman Oil and Gas Limited is engaged in the exploration, development, and production of helium, hydrogen, and hydrocarbons across the U.S. and Australia. The company focuses on projects that can generate operational cash flow while maintaining significant development upside. In addition to its U.S. portfolio, Mosman also holds royalty interests in Australia.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Helix Exploration PLC (LSE:HEX) has reported major operational progress at its flagship Rudyard Project in Montana, bringing the company a step nearer to first helium production. Recent milestones include the mobilization of a PSA plant, completion of key site preparations, and active negotiations with industrial gas buyers over potential off-take agreements.

The company expects to begin production shortly after the final equipment components are delivered in November 2025 — a pivotal moment that could establish Helix as a leading helium producer in Montana. This step is set to strengthen its market position and deliver meaningful value to shareholders as it transitions from development to production.

About Helix Exploration

Helix Exploration PLC is a dedicated helium exploration and development company operating within the Montana Helium Fairway. Founded by industry specialists, the company capitalizes on existing infrastructure and low-cost processing methods to efficiently commercialize its resources. Its Rudyard Project in northern Montana includes four production wells, with the goal of generating strong, sustained revenue over the project’s life cycle.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Altona Rare Earths Plc (LSE:REE) has strengthened its financial footing by securing £600,000 through the exercise of existing warrants. The proceeds will be used to repay outstanding debt, following on from a previous successful fundraising round. In addition, the company has extended its £500,000 debt facility with Catalyse Capital Limited, further reinforcing its liquidity position and providing added flexibility to support project development.

Altona has also appointed Zeus Capital Limited as its corporate broker — a strategic move aimed at increasing its visibility in the capital markets. Together, these financial initiatives are expected to enhance operational capacity and support long-term value creation for shareholders as the company advances its portfolio of critical mineral projects across Africa.

About Altona Rare Earths

Altona Rare Earths Plc is a London Main Market-listed exploration and development company dedicated to unlocking the potential of critical raw materials in Africa. Its flagship Monte Muambe Project in Mozambique contains rare earth elements, fluorspar, and gallium mineralisation. The company is progressing the rare earths initiative in collaboration with the US Government as a potential strategic partner, while also accelerating development of its fluorspar assets. In addition, Altona is advancing exploration at the Sesana Copper-Silver Project in Botswana as part of its broader growth and diversification strategy.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Angus Energy (LSE:ANGS) has unveiled plans for a potential debt restructuring agreement with Trafigura, a move aimed at strengthening its financial foundation and supporting future growth initiatives. By restructuring its debt, the company expects to enhance its ability to access new capital, paving the way for expanded production, organic growth, and possible merger and acquisition opportunities.

In parallel, Angus Energy is carrying out due diligence on a potential acquisition involving producing assets in the Gulf of America. A final decision from the board on whether to proceed with the deal is still pending, but the move reflects the company’s efforts to diversify its portfolio and boost production capacity.

Despite these strategic initiatives, the company faces notable financial headwinds. Persistent revenue declines and weak profitability continue to weigh on its performance. Technical indicators currently signal neutral momentum, and valuation remains pressured by negative earnings. However, management’s operational plans and ongoing restructuring efforts offer some positive signals for longer-term recovery.

About Angus Energy

Angus Energy plc is a UK AIM-listed independent oil and gas company and one of the leading onshore gas producers in the United Kingdom. Its core operations focus on expanding domestic production and pursuing international opportunities. The company holds a 100% interest in the Saltfleetby Gas Field, majority stakes in the Brockham and Lidsey oil fields, and a 25% interest in the Balcombe Licence. Angus operates all the fields in which it maintains an ownership stake.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Ferro-Alloy Resources Limited (LSE:FAR) has released encouraging findings from its feasibility study for Phase 1 of the Balasausqandiq vanadium development. The study outlines a net present value of approximately $748 million and an internal rate of return of 22%, signaling the project’s potential to become a major low-cost producer in the global vanadium market.

The company noted that there is room to unlock additional value through process improvements and operational efficiencies. It is currently in active discussions with financial institutions to secure the necessary funding, with a focus on optimizing production economics to strengthen the project’s profitability. This positions Ferro-Alloy strategically as the vanadium market heads toward a projected supply shortfall by 2029.

Despite the promising project metrics, the company’s financial health remains strained. Weak revenues and ongoing losses highlight elevated risks. Although technical indicators show solid momentum, the overbought status of the stock signals the need for investor caution. Its negative P/E ratio and absence of dividend yield continue to weigh on overall valuation.

About Ferro-Alloy Resources

Ferro-Alloy Resources operates within the mining sector, specializing in vanadium extraction and production. Its flagship asset is the Balasausqandiq deposit in southern Kazakhstan, which has the potential to rank among the world’s largest and lowest-cost sources of vanadium. Alongside this project, the company is exploring additional product streams and engineering enhancements to strengthen its competitive edge in the growing energy transition metals market.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Ceres Power Holdings (LSE:CWR) recently held its earnings call, offering a balanced view of its progress and challenges. The overall tone was cautiously optimistic, with the company highlighting major achievements in production, strategic partnerships, and financial discipline, while also acknowledging persistent issues such as revenue recognition difficulties, operating losses, and a slowdown in order intake.

Production milestone in South Korea

A key development was the official start of production in partnership with Doosan Corporation in South Korea. This marks a crucial shift for Ceres from a research and development focus to scaled commercial manufacturing.

Major investments and partnerships

Ceres secured significant backing, including a £170 million investment from Delta Electronics to support new manufacturing facilities in Taiwan. The company is also expanding its footprint in India through its partnerships with Shell plc and Thermax Limited, supported by the launch of the HydroGenx Hub.

Strong balance sheet and cost reductions

The company reported a solid financial position, with more than £100 million in cash and positive cash flow. Ceres also exceeded its cost-reduction goal, cutting operating expenses by 17% versus its original 15% target, as part of a broader operational efficiency plan.

High margins and business transformation

Ceres continues to maintain industry-leading gross margins, giving it flexibility to reinvest in growth. To address structural challenges, it has announced a business transformation program aimed at cutting costs by 20% and sharpening its commercial focus.

Revenue recognition and forecasting challenges

The company faces ongoing uncertainty around revenue recognition, driven by the complexity of its manufacturing license agreements (MLAs) and accounting standards such as IFRS 15. The timing of new MLA signings remains unclear, adding pressure to forecasting efforts.

Losses and weaker order intake

Despite generating revenue, Ceres continues to operate at a loss, primarily due to heavy investment in stack platform development. Order intake also fell sharply to £0.9 million, down from the prior year, signaling a key area for improvement.

Looking ahead

Ceres aims to execute its transformation plan to lower operating expenses by about 20% and position itself more competitively in the growing power and hydrogen markets, which are expected to expand significantly by 2030.

In short, Ceres Power is navigating a mix of progress and pressure points. While revenue recognition challenges, losses, and weak order growth remain hurdles, the company’s strong financial position, strategic partnerships, and operational focus set the stage for future growth opportunities.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.